These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 15120630)

  • 41. Mono and bivalent binding of a scFv and covalent diabody to murine laminin-1 using radioiodinated proteins and SPR measurements: effects on tissue retention in vivo.
    Huang BC; Davern S; Kennel SJ
    J Immunol Methods; 2006 Jun; 313(1-2):149-60. PubMed ID: 16750217
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A highly stable polyethylene glycol-conjugated human single-chain antibody neutralizing granulocyte-macrophage colony stimulating factor at low nanomolar concentration.
    Krinner EM; Hepp J; Hoffmann P; Bruckmaier S; Petersen L; Petsch S; Parr L; Schuster I; Mangold S; Lorenczewski G; Lutterbüse P; Buziol S; Hochheim I; Volkland J; Mølhøj M; Sriskandarajah M; Strasser M; Itin C; Wolf A; Basu A; Yang K; Filpula D; Sørensen P; Kufer P; Baeuerle P; Raum T
    Protein Eng Des Sel; 2006 Oct; 19(10):461-70. PubMed ID: 16868004
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The influence of the framework core residues on the biophysical properties of immunoglobulin heavy chain variable domains.
    Honegger A; Malebranche AD; Röthlisberger D; Plückthun A
    Protein Eng Des Sel; 2009 Mar; 22(3):121-34. PubMed ID: 19136675
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The IgM CH2 domain as covalently linked homodimerization module for the generation of fusion proteins with dual specificity.
    Seifert O; Plappert A; Heidel N; Fellermeier S; Messerschmidt SK; Richter F; Kontermann RE
    Protein Eng Des Sel; 2012 Oct; 25(10):603-12. PubMed ID: 22988132
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2.
    Biburger M; Weth R; Wels WS
    J Mol Biol; 2005 Mar; 346(5):1299-311. PubMed ID: 15713482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic assessment of SEED: a new engineered antibody platform designed to generate mono- and bispecific antibodies.
    Muda M; Gross AW; Dawson JP; He C; Kurosawa E; Schweickhardt R; Dugas M; Soloviev M; Bernhardt A; Fischer D; Wesolowski JS; Kelton C; Neuteboom B; Hock B
    Protein Eng Des Sel; 2011 May; 24(5):447-54. PubMed ID: 21498564
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
    Wang X; Campoli M; Ko E; Luo W; Ferrone S
    J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A diabody that dissociates to monomer forms at low concentration: effects on binding activity and tumor targeting.
    Huang BC; Foote LJ; Lankford TK; Davern SM; McKeown CK; Kennel SJ
    Biochem Biophys Res Commun; 2005 Feb; 327(4):999-1005. PubMed ID: 15652494
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer].
    Wang Y; Li X; Chen W
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):16-21. PubMed ID: 16495168
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cloning, expression, and identification of anti-carbofuran single chain Fv gene.
    Wang H; Yang J; Liu X; Liang Y; Lei H; Shen Y; Xu X; Sun Y; Xu Z; He Y
    Biotechnol Prog; 2009; 25(4):1018-24. PubMed ID: 19653307
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nanocell targeting using engineered bispecific antibodies.
    Taylor K; Howard CB; Jones ML; Sedliarou I; MacDiarmid J; Brahmbhatt H; Munro TP; Mahler SM
    MAbs; 2015; 7(1):53-65. PubMed ID: 25523746
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cloning, expression and characterisation of a single-chain Fv antibody fragment against domoic acid in Escherichia coli.
    Hu X; O'Dwyer R; Wall JG
    J Biotechnol; 2005 Oct; 120(1):38-45. PubMed ID: 16019098
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Generation and characterization of a single gene-encoded single-chain-tetravalent antitumor antibody.
    Santos AD; Kashmiri SV; Hand PH; Schlom J; Padlan EA
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3118s-3123s. PubMed ID: 10541352
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design and production of novel tetravalent bispecific antibodies.
    Coloma MJ; Morrison SL
    Nat Biotechnol; 1997 Feb; 15(2):159-63. PubMed ID: 9035142
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficient production of single-chain Fv antibody possessing rare codon linkers in fed-batch fermentation.
    Kumada Y; Sakan Y; Kajihara H; Kihara M; Kikuchi Y; Yamaji H; Seong GH; Katoh S
    J Biosci Bioeng; 2009 Jan; 107(1):73-7. PubMed ID: 19147114
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bacterial expression and in vitro refolding of a single-chain fv antibody specific for human plasma apolipoprotein B-100.
    Lee MH; Park TI; Park YB; Kwak JW
    Protein Expr Purif; 2002 Jun; 25(1):166-73. PubMed ID: 12071712
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Construction and expression of single chain Fv gene against domain II of human VEGF receptor II].
    Li R; Xiong DS; Shao XF; Xu YF; Liu J; Zhu ZP; Yang CZ
    Sheng Wu Gong Cheng Xue Bao; 2004 Mar; 20(2):187-91. PubMed ID: 15969106
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Construction and expression of anti-keratin single-chain Fv antibody].
    Zhang GM; Chen YP; Wang G; Liu YF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Nov; 21(6):719-22. PubMed ID: 16256034
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The crystal structure of an anti-CEA scFv diabody assembled from T84.66 scFvs in V(L)-to-V(H) orientation: implications for diabody flexibility.
    Carmichael JA; Power BE; Garrett TP; Yazaki PJ; Shively JE; Raubischek AA; Wu AM; Hudson PJ
    J Mol Biol; 2003 Feb; 326(2):341-51. PubMed ID: 12559905
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine {lambda} to human {lambda} or {kappa} light chains.
    Schlapschy M; Fogarasi M; Gruber H; Gresch O; Schäfer C; Aguib Y; Skerra A
    Protein Eng Des Sel; 2009 Mar; 22(3):175-88. PubMed ID: 19022801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.